Cancer Cells Devour Glutathione as Fuel: What a New Nature Study Means

TL;DR

Researchers at the University of Rochester’s Wilmot Cancer Institute discovered that cancer cells break down glutathione — a popular antioxidant supplement — and use it as fuel to grow. Published in Nature, the study shows tumors are “addicted” to this nutrient source, and blocking their access to it slowed tumor growth in preclinical models. This challenges the assumption that antioxidant supplements are universally beneficial.

Glutathione is one of the most popular antioxidant supplements on the market. It’s marketed as a detoxifier, an immune booster, and a cornerstone of anti-aging protocols.

But a new study published in Nature — one of the world’s most prestigious scientific journals — suggests we may need to rethink that relationship, at least when it comes to cancer.

What the Researchers Found

A team led by Isaac Harris, PhD, at the Wilmot Cancer Institute (University of Rochester) made a surprising discovery: cancer cells actively break down glutathione and consume it as a nutrient source.

This isn’t glutathione doing its usual job of protecting cells from oxidative damage. Instead, tumors are hijacking it — dismantling the molecule to extract cysteine, an amino acid they desperately need to grow.

📚 What Is Glutathione?

Glutathione (GSH) is a tripeptide — a small molecule made of three amino acids: glutamate, cysteine, and glycine. Your body produces it naturally, and it plays a key role in managing oxidative stress. It’s also widely available as a supplement.

The researchers analysed breast tumor samples from tissue donated to Wilmot’s Biobank. When they isolated the fluid inside the tumors, they found abundant stores of glutathione, confirming that tumors aggressively consume it.

"Cancer cells and normal cells potentially use different food sources. We discovered how cancer cells, specifically, break down this antioxidant and use it as fuel."

— Isaac Harris, PhD, Wilmot Cancer Institute

Why This Matters

Nutrients are often scarce in the tissue surrounding tumors. Cancer cells have evolved strategies to scavenge whatever they can from their environment. Until now, most glutathione research focused on its protective, antioxidant role — preventing or repairing cell damage.

This study flips the script: glutathione isn’t just a shield. For cancer cells, it’s food.

The team identified a specific enzyme pathway — γ-glutamyltransferases (GGTs) — that tumors use to break down extracellular glutathione and extract cysteine from it. When researchers blocked this pathway in preclinical models, they were able to slow tumor growth.

🎯 Key Findings

Tumors actively break down glutathione to extract cysteine
This pathway (via GGT enzymes) is a major nutrient source for cancer cells
Blocking GGT activity slowed tumor growth in breast cancer models
The mechanism likely applies to other cancer types as well

The Bigger Picture: Antioxidants and Cancer

This isn’t the first time antioxidants have shown a complicated relationship with cancer. Previous research has found that:

Vitamin E and beta-carotene supplements increased lung cancer risk in smokers (the landmark ATBC and CARET trials)
Taurine, another antioxidant found in supplements and energy drinks, was shown to drive leukemia cell growth in a separate Nature study last year
A whole-food, plant-based diet may reduce pro-tumor fuel sources — work from the same Harris lab that laid the groundwork for this discovery

⚠️ Important Context

This study does not prove that taking glutathione supplements causes cancer. What it shows is that tumors can exploit glutathione as a nutrient source. The relationship between supplements and cancer risk is complex and requires more research. If you have concerns, talk to your doctor.

What This Means for Metabolic Health

For those of us focused on metabolic health, this study reinforces a principle we’ve discussed before: the metabolic environment around cells matters enormously.

Cancer cells are metabolically flexible — they’ll use whatever fuel is available. This is the same principle behind research into:

Ketogenic approaches to cancer therapy — restricting glucose availability to starve tumors
Fasting and nutrient restriction — limiting the raw materials tumors need
Metabolic interventions as adjuncts to traditional treatments

The glutathione discovery adds another dimension: it’s not just about restricting glucose or glutamine. Tumors have a broader metabolic “pantry” than we realised.

"Maybe we need to re-examine the pantry that cancer relies on and look at things that we never thought could actually be used as food for tumors."

— Isaac Harris, PhD, Wilmot Cancer Institute

The Supplement Question

Does this mean you should stop taking glutathione? Not necessarily. Here’s the nuanced take:

Your body makes glutathione naturally. It’s essential for normal cellular function.
The study focused on how tumors exploit it, not on whether supplementation increases cancer risk.
The research was conducted in preclinical models (tissue samples and animal models). Human clinical data on supplementation and cancer risk is still limited.
The National Cancer Institute already urges caution about the relationship between dietary supplements and cancer.

The takeaway isn’t to fear glutathione. It’s to recognise that the “more antioxidants = better” narrative is oversimplified. Biological systems are complex, and what’s beneficial in one context can be exploited in another.

🎯 Practical Takeaways

Be sceptical of blanket claims that any supplement is universally beneficial
The metabolic environment matters — for both health and disease
Whole-food nutrition remains the safest foundation for metabolic health
Discuss supplement use with your doctor, especially if you have cancer risk factors
Watch this space — the Harris team is investigating drugs that could block tumors’ access to glutathione

What Comes Next

The researchers are now developing therapeutic strategies to block the GGT pathway — essentially cutting off the tumors’ glutathione supply line. Early results in preclinical models are promising, and this could eventually lead to new treatments that work alongside existing cancer therapies.

For those following the metabolic health space, this study is another reminder: metabolism is at the heart of disease. Whether it’s insulin resistance, fatty liver, or cancer — understanding how cells use (and misuse) nutrients is the frontier of modern medicine.

This article covers peer-reviewed research published in Nature. It is not medical advice. Always consult a healthcare professional about supplement use and cancer risk.